151 related articles for article (PubMed ID: 27798154)
1. ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo.
Gigliotti CL; Boggio E; Clemente N; Shivakumar Y; Toth E; Sblattero D; D'Amelio P; Isaia GC; Dianzani C; Yagi J; Rojo JM; Chiocchetti A; Boldorini R; Bosetti M; Dianzani U
J Immunol; 2016 Nov; 197(10):3905-3916. PubMed ID: 27798154
[TBL] [Abstract][Full Text] [Related]
2. Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells.
Occhipinti S; Dianzani C; Chiocchetti A; Boggio E; Clemente N; Gigliotti CL; Soluri MF; Minelli R; Fantozzi R; Yagi J; Rojo JM; Sblattero D; Giovarelli M; Dianzani U
J Immunol; 2013 Feb; 190(3):1125-34. PubMed ID: 23275603
[TBL] [Abstract][Full Text] [Related]
3. B7h triggering inhibits the migration of tumor cell lines.
Dianzani C; Minelli R; Gigliotti CL; Occhipinti S; Giovarelli M; Conti L; Boggio E; Shivakumar Y; Baldanzi G; Malacarne V; Orilieri E; Cappellano G; Fantozzi R; Sblattero D; Yagi J; Rojo JM; Chiocchetti A; Dianzani U
J Immunol; 2014 May; 192(10):4921-31. PubMed ID: 24729612
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of T-cell expansion caused by inducible costimulator/B7h costimulation blockade in direct allorecognition pathway.
Du JF; Li QY; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
Transplant Proc; 2011 Dec; 43(10):3960-3. PubMed ID: 22172879
[TBL] [Abstract][Full Text] [Related]
5. B7h-expressing dendritic cells and plasma B cells mediate distinct outcomes of ICOS costimulation in T cell-dependent antibody responses.
Larimore K; Liang L; Bakkour S; Sha WC
BMC Immunol; 2012 Jun; 13():29. PubMed ID: 22686515
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1.
Mesturini R; Gigliotti CL; Orilieri E; Cappellano G; Soluri MF; Boggio E; Woldetsadik A; Dianzani C; Sblattero D; Chiocchetti A; Yagi J; Rojo JM; Dianzani U
Cytokine; 2013 Oct; 64(1):322-30. PubMed ID: 23778031
[TBL] [Abstract][Full Text] [Related]
7. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
8. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
[TBL] [Abstract][Full Text] [Related]
9. Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression.
Kim HJ; Hong J; Jung JW; Kim TH; Kim JA; Kim YH; Kim SY
Int Immunopharmacol; 2010 Nov; 10(11):1440-7. PubMed ID: 20831919
[TBL] [Abstract][Full Text] [Related]
10. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
11. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
12. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
13. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
15. Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption.
Jang JS; Kang IS; Cha YN; Lee ZH; Dinauer MC; Kim YJ; Kim C
BMB Rep; 2019 Nov; 52(11):659-664. PubMed ID: 31072447
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic insight into osteoclast differentiation in osteoimmunology.
Takayanagi H
J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
[TBL] [Abstract][Full Text] [Related]
19. Human circulating monocytes can express receptor activator of nuclear factor-kappaB ligand and differentiate into functional osteoclasts without exogenous stimulation.
Seta N; Okazaki Y; Kuwana M
Immunol Cell Biol; 2008 Jul; 86(5):453-9. PubMed ID: 18301383
[TBL] [Abstract][Full Text] [Related]
20. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
